ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,823 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselScailyte AG
Scailyte AG Logo
Verified· 3 sources

Scailyte AG

Summary

About the company

The core activity of Scailyte is the development and application of digital solutions for single-cell analysis, particularly in the field of cell therapy. The company focuses on the development of biomarkers and the application of artificial intelligence and machine learning in single-cell biology. Scailyte provides solutions for the pharmaceutical, biotech, and clinical research industries and develops products such as ScaiVision, a system for single-cell analysis.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Medical Technology Industry
Software Development
✓ Offered6
AI-supported drug and biomarker discovery
AI-powered discovery and translation of disease-driving cellular states from single-cell and spatial data, combined with multimodal data, machine learning and biological expertise for diagnostic and therapeutic models.
Patient endotyping and precise stratification
Patient endotyping based on single-cell and spatial-omics data with longitudinal clinical outcomes to identify responder signatures and for study stratification.
Target discovery and combination drug discovery
Target discovery and combination-therapy positioning with deep spatial-omics data to uncover mechanistic escape routes and new targets in refractory populations.
Predictive diagnostics and companion diagnostics
Co-development of predictive biomarkers and robust assays up to companion diagnostics, to predict patient responses and enable clinical differentiation.
Diagnostic development and licensing partnerships
Development and validation of diagnostic prototypes with subsequent commercialization, strategic partnership or licensing, including patented assets.
Press

Media

January 4, 2024Media
Hera Biotech acquires endometriosis diagnostic assets from Scailyte
startupticker.ch
December 6, 2023Media
ETH-Spinoff Scailyte nimmt 8 Millionen Franken ein
inside-it.ch
Comparisons

Scailyte AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Scailyte AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Scailyte AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Lichtstrasse 35
4056 Basel

At a glance

Legal form
Corporation
UID
CHE-373.612.844
Founded
2017 · 9 years
Last commercial register change
May 27, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Scailyte AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

RG
RXcel GmbH
Basel
FT
FoRx Therapeutics AG
Basel
LT
LifeMine Therapeutics (Switzerland) GmbH
Basel
AG
AlphaMeld GmbH
Basel
3B
3T Biosciences Europe GmbH
Basel
BA
BioVersys AG
Basel
IP
Ironwood Pharmaceuticals GmbH
Basel
RS
Regeneron Switzerland GmbH
Basel